Mr. Steven D. Skolsky

Steven D. Skolsky was born in 1956 and is a U.S. citizen. He holds a BA degree in Biology from the University of North Carolina at Chapel Hill, USA. Mr. Skolsky has over 25 years of general management and international pharmaceutical industry experience with emphasis on product strategy, commercialization and product development. He currently is a member of the Board of Directors of Adherex Technologies Inc., USA, and holds the position of Global Head of Clinical and Data Operations at Quintiles Transnational, a leading Clinical Research Organization, after serving as Principal of EXPIS Partners, USA, a strategic life science consultancy. He previously served as President and Chief Executive Officer of Sequoia Pharmaceuticals, a privately held U.S. based company specializing in novel antiviral therapeutics. Prior to his appointment at Sequoia, he held the position of Chief Executive Officer at Trimeris, Inc., a publicly held U.S. based company that discovered and commercialized Fuzeon®, a first-in-class HIV therapeutic in collaboration with partner F. Hoffmann-La Roche. Previously, Mr. Skolsky served for more than 20 years at GlaxoSmithKline (GSK) in a range of senior leadership roles, including Senior Vice President, Global Product Strategy and Clinical Development, and Managing Director of GSK's operations in Australia and New Zealand.